Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting

Background Weekly paclitaxel has been shown more effective and less toxic than the conventional three-weekly administration. The GEICAM 9906 demonstrated effectiveness and safety of a dose-dense schedule of 100 mg/m 2 of paclitaxel given over 8 weeks (w). This schedule has been adopted at our instit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer (Tokyo, Japan) Japan), 2016-03, Vol.23 (2), p.261-265
Hauptverfasser:	Santana, Iuri A., Oliveira, Julia Andrade, da Silva Lima, Julianne Maria, Testa, Laura, Piato, José Roberto M., Hoff, Paulo M., Mano, Max S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Adult Aged Antineoplastic Agents, Phytogenic - therapeutic use Biomarkers, Tumor - metabolism Brazil Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - pathology Cancer Cancer Research Care and treatment Drug Administration Schedule Feasibility Studies Female Follow-Up Studies Humans Immunoenzyme Techniques Medicine Medicine & Public Health Middle Aged Neoplasm Staging Oncology Original Article Paclitaxel - therapeutic use Prognosis Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Retrospective Studies Surgery Surgical Oncology Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!